In 2023, the total number of 10% top-cited scientific publications in immunology and microbiology in China was approximately 1.1 thousand. From 2024 onward, the forecast data indicates a steady growth in such publications, increasing from 1.2 to 1.59 thousand by 2028. The year-on-year growth shows a consistent upward trend, with an average CAGR of roughly 6.98% over the forecast period. This suggests a robust and persistent emphasis on research output quality in these fields.

Future trends to watch for include:

Continued investment and collaboration in Chinese scientific research to maintain growth momentum.
Potential growth in cross-disciplinary studies that integrate immunology and microbiology with emerging technologies.
The impact of increased international cooperation and policy changes on research output and citation impacts.